Evidence map›Paper›PMID 40211196›Full record

ArticleBMC medical imaging2025

A new scoring system for risk stratification of thyroid tumors.

Ya Yuan, Hua Shu, Lu Li, Liuxi Wu, Fei Yu

Abstract read
In one paragraph

Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ya Yuan *Department of Ultrasound, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu Province, 210029, China.
Hua ShuDepartment of Ultrasound, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu Province, 210029, China.
Lu LiDepartment of Ultrasound, The First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu Province, 210029, China.
Liuxi WuDepartment of Ultrasound, Nanjing Drum Tower Hospital, Nanjing, Jiangsu Province, 210000, China.
Fei YuDepartment of Nuclear Medicine, Shanghai Tenth People's Hospital with Nanjing Medical University, Shanghai, 200072, China. yufei021@sina.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo develop an ultrasound feature-based risk stratification system for differentiating benign, low-risk and malignant thyroid tumors and compare it with existing TI-RADS.

methodsThe retrospective study included patients who underwent preoperative neck ultrasound examination from January 2018 to June 2023, and their ultrasound characteristics were recorded. According to surgical pathological findings, they were classified into three categories: benign, low-risk, and malignant. Univariable and multivariable logistic regression analyses were used to assess the association of qualitative ultrasound features with different risk stratifications and a new scoring system was established to evaluate its diagnostic efficacy, and to compare it with TI-RADS.

resultsAspect ratio ≥1 was an independent risk factor in the comparison of benign and low-risk thyroid nodules, and in the comparison of benign and malignant nodules, hypoechoic,irregular margin,nodule max diameter ≤1 cm,the aspect ratio ≥1 and elasticity score ≥3 were independent risk factors. According to the multivariate analysis, they were assigned 1, 2, 2, 3, 2/4 points respectively, and we established a new scoring system. According to ROC analysis, the total score of 0-4.5 was considered as benign nodules, 4.5-5.5 was considered as low-risk nodules, and more than 5.5 were considered as malignant nodules. Compared it to ACR-TI-RADS, this scoring system performed better than in differentiating benign and malignant nodules (P = 0.001, P = 0.018, respectively).

conclusionThe scoring system based on ultrasound features established in this study can be used for risk stratification of thyroid nodules more efficiently, it has higher sensitivity and specificity for the differentiation of benign and malignant nodules.

Indexed as

Thyroid NeoplasmsThyroid NoduleAdultAgedDiagnosis, DifferentialFemaleHumansMaleMiddle AgedRetrospective StudiesRisk AssessmentRisk FactorsROC CurveSensitivity and SpecificityUltrasonographyRisk stratificationThyroid tumorsTI-RADS

Identifiers

PMID40211196
PMCPMC11983903

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.